Plus Therapeutics Inc (NASDAQ:PSTV) does about 17.24M shares in volume on a normal day but saw 4152374 shares change hands in the recent trading day. The company now has a market cap of 7.14M USD. Its current market price is $0.42, marking a decrease of -17.09% compared to the previous close of $0.51. The 52 week high reached by this stock is $2.67 whilst the lowest price level in 52 weeks is $0.24.
Plus Therapeutics Inc (PSTV) has a 20-day trading average at $0.6717 and the current price is -84.27% off the 52-week high compared with 75.00% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.8465 and its 200-day simple moving average is $1.1869. If we look at the stock’s price movements over the week, volatility stands at 25.27%, which decreases to 19.36% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 36.69 to suggest the stock is neutral.
The consensus objective for the share price is $9.62, suggesting that the stock has a potential upside of 95.63% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 17, 2025 when D. Boral Capital initiated the stock to “Buy” and issued a price target of $9. Maxim Group initiated its price target at $6.
The current price level is -37.47%, -50.39%, and -64.61% away from its SMA20, SMA50, and SMA200 respectively, with the PSTV price moving above the 50-day SMA on current market day. Plus Therapeutics Inc (PSTV) stock is down -36.36% over the week and -37.47% over the past month. Its price is -63.48% year-to-date and -80.65% over the past year.
To reach the target analysts have set, the stock logically needs to grow 95.63 percent from here.
Outstanding shares total 17.00M with insiders holding 6.07% of the shares and institutional holders owning 7.50% of the company’s common stock. The beta has a value of 0.76. Price to sales ratio is 1.23.
